These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29516347)

  • 1. Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites.
    Kim MJ; Byeon JY; Kim YH; Kim SH; Lee CM; Jung EH; Chae WK; Lee YJ; Jang CG; Lee SY; Choi CI
    Arch Pharm Res; 2018 Mar; 41(3):347-353. PubMed ID: 29516347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites.
    Mürdter TE; Kerb R; Turpeinen M; Schroth W; Ganchev B; Böhmer GM; Igel S; Schaeffeler E; Zanger U; Brauch H; Schwab M
    Hum Mol Genet; 2012 Mar; 21(5):1145-54. PubMed ID: 22108178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites.
    Byeon JY; Kim YH; Na HS; Jang JH; Kim SH; Lee YJ; Bae JW; Kim IS; Jang CG; Chung MW; Lee SY
    Arch Pharm Res; 2015 Nov; 38(11):2083-91. PubMed ID: 26254792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.
    Jung EH; Lee YJ; Kim DH; Kang P; Lim CW; Cho CK; Jang CG; Lee SY; Bae JW
    Arch Pharm Res; 2020 Dec; 43(12):1356-1363. PubMed ID: 33245517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Polymorphism of CYP2D6 and Clomiphene Concentrations in Infertile Patients with Ovulatory Dysfunction Treated with Clomiphene Citrate.
    Ji M; Kim KR; Lee W; Choe W; Chun S; Min WK
    J Korean Med Sci; 2016 Feb; 31(2):310-4. PubMed ID: 26839488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine.
    Byeon JY; Lee CM; Lee YJ; Kim YH; Kim SH; Jung EH; Chae WK; Lee YJ; Jang CG; Lee SY
    Arch Pharm Res; 2019 Feb; 42(2):182-190. PubMed ID: 30542809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone.
    Cho CK; Byeon JY; Kang P; Park JI; Jang CG; Lee SY; Choi CI; Bae JW; Lee YJ
    Arch Pharm Res; 2023 Jan; 46(1):59-64. PubMed ID: 36542291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide.
    Bae JW; Oh KY; Yoon SJ; Shin HB; Jung EH; Cho CK; Lim CW; Kang P; Choi CI; Jang CG; Lee SY; Lee YJ
    Arch Pharm Res; 2020 Nov; 43(11):1207-1213. PubMed ID: 33247397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CYP3A5 and CYP2D6 genetic polymorphism on the pharmacokinetics of diltiazem and its metabolites in Chinese subjects.
    Zheng T; Su CH; Zhao J; Zhang XJ; Zhang TY; Zhang LR; Kan QC; Zhang SJ
    Pharmazie; 2013 Apr; 68(4):257-60. PubMed ID: 23700791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes.
    Byeon JY; Lee YJ; Kim YH; Kim SH; Lee CM; Bae JW; Jang CG; Lee SY; Choi CI
    Arch Pharm Res; 2018 May; 41(5):564-570. PubMed ID: 29728928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
    Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
    Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects.
    Kim MK; Cho JY; Lim HS; Hong KS; Chung JY; Bae KS; Oh DS; Shin SG; Lee SH; Lee DH; Min B; Jang IJ
    Eur J Clin Pharmacol; 2003 Jun; 59(2):111-6. PubMed ID: 12728290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers.
    Pawlowska M; Bogiel M; Duda J; Sieradzki E
    Eur J Clin Pharmacol; 2015 Jun; 71(6):699-705. PubMed ID: 25953735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
    Lim KS; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Cho JY; Shin SG; Yu KS
    Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers.
    Kirchheiner J; Meineke I; Müller G; Bauer S; Rohde W; Meisel C; Roots I; Brockmöller J
    Clin Pharmacokinet; 2004; 43(4):267-78. PubMed ID: 15005635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects.
    Yin OQ; Mak VW; Hu M; Fok BS; Chow MS; Tomlinson B
    Eur J Clin Pharmacol; 2012 Jun; 68(6):943-9. PubMed ID: 22281720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects.
    Jung EH; Lee CM; Byeon JY; Shin HB; Oh KY; Cho CK; Lim CW; Jang CG; Lee SY; Lee YJ
    Arch Pharm Res; 2020 Sep; 43(9):976-981. PubMed ID: 32661920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of CYP2D6
    Pei Q; Huang L; Huang J; Gu JK; Kuang Y; Zuo XC; Ding JJ; Tan HY; Guo CX; Liu SK; Yang GP
    Acta Pharmacol Sin; 2016 Nov; 37(11):1499-1508. PubMed ID: 27665849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.